natgillin/translations-raw huggingface dataset:
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC [1], and in particular Article 78(2) thereof,
uzimajući u obzir Uredbu (EZ) br. 1107/2009 Europskog parlamenta i Vijeća od 21. listopada 2009. o stavljanju na tržište sredstava za zaštitu bilja i stavljanju izvan snage direktiva Vijeća 79/117/EEZ i 91/414/EEZ [1], a posebno njezin članak 78. stavak 2.,
Active substances are to be identified as candidates for substitution if they meet one or more criteria set out in point 4 of Annex II to Regulation (EC) No 1107/2009.
Aktivne tvari utvrđuju se kao kandidati za zamjenu ako ispunjavaju jedan ili više mjerila iz Priloga II. točke 4. Uredbe (EZ) br. 1107/2009.
Pursuant to Article 80(7) of Regulation (EC) No 1107/2009, the Commission has to establish a list of substances included in Annex I to Council Directive 91/414/EEC [2] which satisfy the criteria set out in point 4 of Annex II to Regulation (EC) No 1107/2009, hereinafter: ‘list of candidates for substitution’.
U skladu s člankom 80. stavkom 7. Uredbe (EZ) br. 1107/2009 Komisija mora izraditi popis tvari uvrštenih u Prilog I. Direktivi Vijeća 91/414/EEZ [2] koje ispunjavaju mjerila utvrđena u Prilogu II. točki 4. Uredbe (EZ) br. 1107/2009, dalje u tekstu: „popis kandidata za zamjenu”.
To ensure the consistency of the policy of the Union as regards active substances that have properties identifying them as candidates for substitution and to apply equal treatment to such substances, the Commission should also include in that list active substances approved under Regulation (EC) No 1107/2009 pursuant to the transitional provisions of Article 80(1).
Kako bi se osigurala dosljednost politike Unije u pogledu aktivnih tvari koje imaju svojstva kojima ih se utvrđuje kao kandidate za zamjenu te kako bi se na te tvari primijenio jednak tretman, Komisija bi trebala u taj popis uvrstiti i aktivne tvari odobrene u skladu s Uredbom (EZ) br. 1107/2009 u skladu s prijelaznim odredbama članka 80. stavka 1.
From the information contained in either the review report, or the conclusions of the European Food Safety Authority [3] or the Draft Assessment Report and related addenda and peer review reports, or from the classification in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Council [4], it was possible to identify the substances which satisfy the criteria set out in point 4 of Annex II to Regulation (EC) No 1107/2009.
Iz informacija koje se nalaze u izvješću o pregledu, zaključcima Europske agencije za sigurnost hrane [3] ili nacrtu izvješća o ocjeni i povezanim dopunama i izvješćima o stručnoj procjeni, ili iz razvrstavanja u skladu s Uredbom (EZ) br. 1272/2008 Europskog parlamenta i Vijeća [4], bilo je moguće utvrditi tvari koje ispunjavaju mjerila iz Priloga II. točke 4. Uredbe (EZ) br. 1107/2009.
These documents provide information, where relevant, concerning the applicable Acceptable Daily Intake (ADI), Acute Reference Dose (ARfD) or Acceptable Operator Exposure Level (AOEL), the information concerning persistent, bio-accumulative and toxic (PBT) properties of the substances, information concerning critical effects referred to in the third indent of point 4 of Annex II to Regulation (EC) No 1107/2009, the proportion of non-active isomers, the classification in accordance with Regulation (EC) No 1272/2008, as carcinogen category 1A or 1B and toxic for reproduction category 1A or 1B, the endocrine disrupting properties.
Ti dokumenti po potrebi sadržavaju informacije o primjenjivom prihvatljivom dnevnom unosu (ADI), akutnoj referentnoj dozi (ARfD) ili dopuštenoj razini izloženosti primjenitelja (AOEL), informacije o dugotrajnim, biološki kumulativnim i toksičnim (PBT) svojstvima tvari, informacije o kritičnim učincima iz Priloga II. točke 4. treće alineje Uredbe (EZ) br. 1107/2009, udjelu neaktivnih izomera, razvrstavanju u skladu s Uredbom (EZ) br. 1272/2008 kao karcinogene tvari 1.A ili 1.B kategorije i reproduktivno toksične 1.A ili 1.B kategorije, endokrino štetnim svojstvima.
Based on that information, the substances set out in the Annex to this Regulation were identified as satisfying one or more criteria set out in point 4 of Annex II to Regulation (EC) No 1107/2009.
Na temelju navedenih informacija utvrđeno je da tvari iz Priloga ovoj Uredbi ispunjavaju jedno mjerilo ili više njih iz Priloga II. točke 4. Uredbe (EZ) br. 1107/2009.
The information has been consolidated and can be found in a support tool for the establishment of the list of candidates for substitution, which is available on the Commission website [5].
Informacije su konsolidirane i nalaze se u alatu za potporu u izradi popisa kandidata za zamjenu koji je dostupan na internetskim stranicama Komisije [5].
The Acceptable Daily Intake (ADI) of the active substances 1-methylcyclopropene, amitrole, diclofop, dimethoate, ethoprophos, fenamiphos, fipronil, fluometuron, haloxyfop-P, metam, oxamyl, sulcotrione and triazoxide is significantly lower than that of the majority of the approved active substances within their respective groups of substances/use categories.
Prihvatljivi dnevni unos (ADI) za aktivne tvari 1-metilciklopropen, amitrol, diklofop, dimetoat, etoprofos, fenamifos, fipronil, fluometuron, haloksifop-P, metam, oksamil, sulkotrion i triazoksid znatno je niži od vrijednosti za većinu odobrenih aktivnih tvari unutar njihovih skupina tvari/kategorija uporabe.
The Acute Reference Dose (ARfD) of the active substances dimoxystrobin, fenamiphos, methomyl and oxamyl is significantly lower than that of the majority of the approved active substances within their respective groups of substances/use categories.
Akutna referentna doza (ARfD) za aktivne tvari dimoksistrobin, fenamifos, metomil and oksamil znatno je niža od vrijednosti za većinu odobrenih aktivnih tvari unutar njihovih skupina tvari/kategorija uporabe.
The Acceptable Operator Exposure Level (AOEL) of the active substances amitrole, bromadiolone, difenacoum, dimethoate, diquat, ethoprophos, fenamiphos, fluquinconazole, metam, sulcotrione, triazoxide and warfarin is significantly lower than that of the majority of the approved active substances within their respective groups of substances/use categories.
Dopuštena razina izloženosti primjenitelja (AOEL) za aktivne tvari amitrol, bromadiolon, difenakum, dimetoat, dikvat, etoprofos, fenamifos, flukvinkonazol, metam, sulkotrion, triazoksid i varfarin znatno je niža od vrijednosti za većinu odobrenih aktivnih tvari unutar njihovih skupina tvari/kategorija uporabe.
It is therefore appropriate to include those active substances in the list of candidates for substitution.
Stoga je primjereno te aktivne tvari uvrstiti u popis kandidata za zamjenu.
The active substances lufenuron, oxyfluorfen and quinoxyfen meet the criteria to be considered a persistent and bioaccumulative substance.
Aktivne tvari lufenuron, oksifluorfen i kinoksifen ispunjavaju mjerila na temelju kojih se mogu smatrati dugotrajnim i biološki kumulativnim tvarima.
The active substances amitrole, bifenthrin, bromuconazole, chlorotoluron (unstated stereochemistry), copper compounds (variants copper hydroxide, copper oxychloride, copper oxide, Bordeaux mixture and tribasic copper sulphate), cyproconazole, cyprodinil, difenoconazole, diflufenican, dimoxystrobin, diquat, epoxiconazole, fenbutatin oxide, fludioxonil, flufenacet, fluopicolide, fluquinconazole, haloxyfop-P, imazamox, imazosulfuron, isoproturon, isopyrazam, lenacil, lufenuron, metconazole, metribuzin, metsulfuron-methyl, myclobutanil, nicosulfuron, oxadiazon, oxyfluorfen, paclobutrazol, pirimicarb, prochloraz, propiconazole, propoxycarbazone, prosulfuron, quinoxyfen, tebuconazole, tebufenpyrad, tepraloxydim, tri-allate, triasulfuron and ziram meet the criteria to be considered a persistent and toxic substance.
Aktivne tvari amitrol, bifentrin, bromkonazol, klorotoluron (stereokemija nije određena), spojevi bakra (inačice bakrenog hidroksida, bakrenog oksiklorida, bakrenog oksida, bordoške juhe i trivalentnog bakrenog sulfata), ciprokonazol, ciprodinil, difenkonazol, diflufenikan, dimoksistrobin, dikvat, epoksikonazol, fenbutatin oksid, fludioksonil, flufenacet, fluopikolid, flukvinokonazol, haloksifop-P, imazamoks, imazosulfuron, izoproturon, izopirazam, lenacil, lufenuron, metkonazol, metribuzin, metsulfuron-metil, miklobutanil, nikosulfuron, oksadiazon, oksifluorfen, paklobutrazol, pirimikarb, prokloraz, propikonazol, propoksikarbazon, prosulfuron, kinoksifen, tebukonazol, tebufenpirad, tepraloksidim, trialat, triasulfuron i ciram ispunjavaju mjerila na temelju kojih se mogu smatrati dugotrajnim i toksičnim tvarima.
The active substances aclonifen, difenacoum, esfenvalerate, etofenprox, etoxazole, famoxadone, lambda-cyhalothrin, lufenuron, oxyfluorfen, pendimethalin and quinoxyfen meet the criteria to be considered a bioaccumulative and toxic substance.
Aktivne tvari aklonifen, difenakum, esfenvalerat, etofenproks, etoksazol, famoksadon, lambda-cihalotrin, lufenuron, oksifluorfen, pendimetalin i kinoksifen ispunjavaju mjerila po kojima ih se može smatrati biološki kumulativnim i toksičnim tvarima.
The active substances mecoprop and metalaxyl contain a significant proportion of non-active isomers.
Aktivne tvari mekoprop i metalaksil sadržavaju znatan udio neaktivnih izomera.
Since measures concerning specific scientific criteria for the determination of endocrine disrupting properties, as referred to in the first paragraph of point 3.6.5 of Annex II to Regulation (EC) No 1107/2009, have not yet been adopted, it was to be established in accordance with the third paragraph thereof whether a substance is to be considered as having such properties.
S obzirom na to da mjere o posebnim znanstvenim mjerilima za utvrđivanje endokrino štetnih svojstava iz Priloga II. točke 3.6.5. prvog stavka Uredbe (EZ) br. 1107/2009 još nisu donesene, trebalo je u skladu s trećim stavkom navedene točke utvrditi smatra li se da tvar posjeduje takva svojstva.
In accordance with that provision the active substances chlorotoluron (unstated stereochemistry), dimoxystrobin, epoxiconazole, molinate, profoxydim, tepraloxydim and thiacloprid are to be considered as having endocrine disrupting properties that may cause adverse effects in humans.
U skladu s tom odredbom za aktivne tvari klorotoluron (stereokemija nije određena), dimoksistrobin, epoksikonazol, molinat, profoksidim, tepraloksidim i tiakloprid smatrat će se da imaju endokrino štetna svojstva koja mogu imati nepovoljne učinke na ljude.
Member States and interested parties should be provided with a reasonable period to adapt to the provisions of this Regulation.
Državama članicama i zainteresiranim strankama trebalo bi osigurati razuman rok za prilagodbu odredbama ove Uredbe.
Candidates for substitution
Kandidati za zamjenu
Active substances included in Annex I to Directive 91/414/EEC which fulfil the criteria set out in point 4 of Annex II to Regulation (EC) No 1107/2009 shall be as set out in the list in the Annex to this Regulation.
Aktivne tvari uvrštene u Prilog I. Direktivi 91/414/EEZ koje ispunjavaju mjerila iz Priloga II. točke 4. Uredbe (EZ) br. 1107/2009 utvrđene su na popisu u Prilogu ovoj Uredbi.
The first paragraph shall also apply to active substances approved under Regulation (EC) No 1107/2009 pursuant to the transitional measures of Article 80(1).
Prvi stavak primjenjuje se i na aktivne tvari odobrene u skladu s Uredbom (EZ) br. 1107/2009 u skladu s prijelaznim mjerama članka 80. stavka 1.
Article 1 and the Annex shall not apply to applications for the authorisation of plant protection products submitted before 1 August 2015.
Članak 1. i Prilog ne primjenjuju se na zahtjeve za odobrenje proizvoda za zaštitu bilja podnesene prije 1. kolovoza 2015.
ethylcyclopropene
etilciklopropen
aclonifen
aklonifen
amitrole
amitrol
bifenthrin
bifentrin
bromadiolone
bromadiolon
bromuconazole
bromkonazol
carbendazim
karbendazim
chlorotoluron (unstated stereochemistry)
klortoluron (stereokemija nije određena)
copper compounds (variants copper hydroxide, copper oxychloride, copper oxide, Bordeaux mixture and tribasic copper sulphate)
spojevi bakra (inačice bakrenog hidroksida, bakrenog oksiklorida, bakrenog oksida, bordoške juhe i trivalentnog bakrenog sulfata)
cyproconazole
ciprokonazol
cyprodinil
ciprodinil
diclofop
diklofop
difenacoum
difenakum
difenoconazole
difenkonazol
diflufenican
diflufenikan
dimethoate
dimetoat
dimoxystrobin
dimoksistrobin
diquat
dikvat
epoxiconazole
epoksikonazol
esfenvalerate
esfenvalerat
ethoprophos
etoprofos
etoxazole
etoksazol
famoxadone
famoksadon
fenamiphos
fenamifos
fenbutatin oxide
fenbutatin oksid
fludioxonil
fludioksonil
flumioxazine
flumioksazin
fluopicolide
fluopikolid
fluquinconazole
flukvinokonazol
glufosinate
glufosinat
haloxyfop-P
haloksifop-P
imazamox
imazamoks
isoproturon
izoproturon
isopyrazam
izopirazam
lambda-cyhalothrin
lambda-cihalotrin
mecoprop
mekoprop
metalaxyl
metalaksil
metconazole
metkonazol
methomyl
metomil
metsulfuron-methyl
metsulfuron-metil
molinate
molinat
myclobutanil
miklobutanil
nicosulfuron
nikosulfuron
oxadiargyl
oksadiagil
oxadiazon
oksadiazon
oxamyl
oksamil
oxyfluorfen
oksifluorfen
paclobutrazol
paklobutrazol
pendimethalin
pendimetalin
pirimicarb
pirimikarb
prochloraz
prokloraz
profoxydim
profoksidim
propiconazole
propikonazol
propoxycarbazone
propoksikarbazon
quinoxyfen
kinoksifen
quizalofop-P (variant quizalofop-P-tefuryl)
kvizalofop-P (inačica kvizalofop-P-tefurila)
sulcotrione
sulkotrion
tebuconazole
tebukonazol
tebufenpyrad
tebufenpirad
tepraloxydim
tepraloksidim
thiacloprid
tiakloprid
tri-allate
trialat
triazoxide
triazoksid
ziram
ciram
The active substances carbendazim, epoxiconazole, flumioxazine, glufosinate, linuron, oxadiargyl, quizalofop-P (variant quizalofop-P-tefuryl) and warfarin are or are to be classified, in accordance with the provisions of Regulation (EC) No 1272/2008, as toxic for reproduction category 1A or 1B.
Aktivne tvari karbendazim, epoksikonazol, flumioksazin, glufosinat, linuron, oksadiargil, kvizalofop-P (inačica kvizalofop-P-tefuri la) i varfarin razvrstane su ili ih se treba razvrstati u skladu s odredbama Uredbe (EZ) br. 1272/2008 kao reproduktivno toksične 1.A ili 1.B. kategorije.
Commission Implementing Regulation (EU) 2015/409
Provedbena uredba Komisije (EU) 2015/409
amending Council Implementing Regulation (EU) No 917/2011 imposing a definitive anti-dumping duty and collecting definitely the provisional duty imposed on imports of ceramic tiles originating in the People's Republic of China
o izmjeni Provedbene uredbe Vijeća (EU) br. 917/2011 o uvođenju konačne antidampinške pristojbe i konačnoj naplati privremene pristojbe uvedene na uvoz keramičkih pločica podrijetlom iz Narodne Republike Kine
Having regard to Council Regulation (EC) No 1225/2009 of 30 November 2009 on protection against dumped imports from countries not members of the European Community [1] (‘the basic Regulation’), and in particular Article 11(3) thereof,
uzimajući u obzir Uredbu Vijeća (EZ) br. 1225/2009 od 30. studenoga 2009. o zaštiti od dampinškog uvoza iz zemalja koje nisu članice Europske zajednice [1] („Osnovna uredba”), a posebno njezin članak 11. stavak 3.,
On 15 September 2011 the Council imposed anti-dumping duties on imports of ceramic tiles originating in the People's Republic of China by Implementing Regulation (EU) No 917/2011 [2] (‘the original Regulation’).
Provedbenom uredbom (EU) br. 917/2011 [2] („Izvorna uredba”) Vijeće je 15. rujna 2011. uvelo antidampinške pristojbe na uvoz keramičkih pločica podrijetlom iz Narodne Republike Kine.
A single duty rate of 26,3 % was imposed on imports of the product concerned manufactured by the following group of exporting producers:
Jedinstvena stopa pristojbe u visini od 26,3 % uvedena je na uvoz predmetnog proizvoda koji proizvodi sljedeća grupa proizvođača izvoznika:
Dongguan City Wonderful Ceramics Industrial Park Co., Ltd and Guangdong Jiamei Ceramics Co. Ltd (together referred to as the Wonderful group), and
Dongguan City Wonderful Ceramics Industrial Park Co., Ltd i Guangdong Jiamei Ceramics Co. Ltd (pod zajedničkim nazivom „grupa Wonderful”), i
Qingyuan Gani Ceramics Co. Ltd and Foshan Gani Ceramics Co. Ltd (together referred to as the Gani group).
Qingyuan Gani Ceramics Co. Ltd i Foshan Gani Ceramics Co. Ltd (pod zajedničkim nazivom „grupa Gani”).
As set out in recitals 96 to 98 of the original Regulation, the European Commission (‘the Commission’) was notified after disclosure of provisional findings that the relationship between the companies had been severed and on that basis individual duties for the Gani group and for the Wonderful group should have been applied.
Kao što je navedeno u uvodnim izjavama 96. do 98. Izvorne uredbe, nakon objavljivanja privremenih nalaza Europska komisija („Komisija”) obaviještena je da je odnos između društava prekinut i da je na osnovi toga trebalo primijeniti pojedinačne pristojbe na grupu Gani i grupu Wonderful.
The request could not be accepted at that stage as its merits needed to be properly examined.
Zahtjev u toj fazi nije bilo moguće prihvatiti jer ga je trebalo primjereno ispitati.
Request for a partial interim review
Zahtjev za djelomičnu privremenu reviziju
On 2 October 2012 the Commission received a request for a partial interim review from the Gani group.
Komisija je 2. listopada 2012. primila zahtjev grupe Gani za djelomičnu privremenu reviziju.
Initiation of a partial interim review
Pokretanje djelomične privremene revizije
The Commission determined, after having consulted the Advisory Committee, that such a review should therefore be opened.
Komisija je nakon savjetovanja sa savjetodavnim odborom odlučila da bi reviziju stoga trebalo pokrenuti.
On 31 January 2014, the Commission initiated a partial interim review of the measures in force on imports into the Union of ceramic tiles originating in the People's Republic of China under Article 11(3) of the basic Regulation.
Komisija je 31. siječnja 2014. pokrenula djelomičnu privremenu reviziju mjera na snazi koje se primjenjuju na uvoz u Uniju keramičkih pločica podrijetlom iz Narodne Republike Kine u skladu s člankom 11. stavkom 3. Osnovne uredbe.
It published a Notice of Initiation in the Official Journal of the European Union [3].
Obavijest o pokretanju postupka objavila je u Službenom listu Europske unije [3].
The review was limited in scope to the examination of the ownership structure of the Gani group and, if warranted, ex officio of the dumping margin as far as the Gani group was concerned.
Revizija je bila ograničena na ispitivanje vlasničke strukture grupe Gani, a po potrebi po službenoj dužnosti ispitana je i dampinška marža koja se odnosi na tu grupu.
The review also covered ex officio the same matters as far as the Wonderful group was concerned.
Revizijom su po službenoj dužnosti obuhvaćena ista pitanja u pogledu društava Dongguan City Wonderful Ceramics Industrial Park Co., Ltd i Guangdong Jiamei Ceramics Co., Ltd (grupa Wonderful).
Review investigation period
Razdoblje ispitnog postupka revizije
The investigation of dumping covered the period from 1 January 2013 to 31 December 2013 (‘the review investigation period’).
Ispitnim postupkom u vezi s dampingom obuhvaćeno je razdoblje od 1. siječnja 2013. do 31. prosinca 2013. („razdoblje ispitnog postupka revizije”).
Parties concerned by the investigation
Strane na koje se ispitni postupak odnosi
The Commission invited both the Gani group and the Wonderful group to cooperate with the investigation and to reply to the Commission's questionnaires.
Komisija je pozvala grupu Gani i grupu Wonderful da surađuju u ispitnom postupku i ispune Komisijine upitnike.
In addition, the Commission provided an opportunity for the companies to request market economy treatment under Article 2(7) of the basic Regulation.
Osim toga Komisija je društvima omogućila da zahtijevaju primjenu pristupa tržišnoga gospodarstva u skladu s člankom 2. stavkom 7. Osnovne uredbe.
In the Notice of Initiation the Commission had provisionally chosen the United States of America as a third market economy country (‘analogue country’) within the meaning of Article 2(7)(a) of the basic Regulation and invited parties to comment on this choice.
U obavijesti o pokretanju postupka Komisija je kao treću zemlju s tržišnim gospodarstvom provizorno odabrala Sjedinjene Američke Države („analogna zemlja”) u smislu članka 2. stavka 7. točke (a) Osnovne uredbe i pozvala strane da dostave očitovanja o tom odabiru.
Interested parties had an opportunity to comment on the initiation of the investigation and to request a hearing with the Commission and/or the Hearing Officer for trade proceedings.
Zainteresirane strane imale su priliku očitovati se o pokretanju ispitnog postupka i zatražiti saslušanje pred Komisijom i/ili službenikom za saslušanje u postupcima koji se odnose na trgovinu.
Questionnaire replies and verification visits
Odgovori na upitnik i posjeti radi provjere
The Commission received questionnaire replies from both groups and also from two analogue country producers.
Komisija je primila odgovore na upitnik od obiju grupa i od dvaju proizvođača iz analogne zemlje.
The Commission sought and verified all the information deemed necessary for the review.
Komisija je tražila i provjerila sve podatke koje je smatrala potrebnima za reviziju.
Verification visits under Article 16 of the basic Regulation were carried out at the premises of the following companies:
Posjeti radi provjere u skladu s člankom 16. Osnovne uredbe obavljeni su u poslovnim prostorima sljedećih društava:
Exporting producers in the country concerned:
proizvođači izvoznici u predmetnoj zemlji:
Qingyuan Gani Ceramics Co. Ltd and
Qingyuan Gani Ceramics Co. Ltd, i
Foshan Gani Ceramics Co. Ltd
Foshan Gani Ceramics Co. Ltd,
Producers in the analogue country that requested confidential treatment on the basis of risk of retaliation.
proizvođači iz analogne zemlje koji su zatražili povjerljivo postupanje zbog rizika od protumjera.
PRODUCT CONCERNED
PREDMETNI PROIZVOD
The product subject to this review is the same as defined in the original Regulation, namely glazed and unglazed ceramic flags and paving, hearth or wall tiles; glazed and unglazed ceramic mosaic cubes and the like, whether or not on a backing (‘the product concerned’), currently falling within CN codes 69071000, 69079020, 69079080, 69081000, 69089011, 69089020, 69089031, 69089051, 69089091, 69089093 and 69089099.
Proizvod koji je predmet ove revizije isti je proizvod koji je definiran u Izvornoj uredbi, tj. glazirane i neglazirane keramičke pločice za popločavanje i oblaganje; glazirane i neglazirane keramičke pločice za mozaik i slično, neovisno o tome jesu li na podlozi ili ne („predmetni proizvod”), trenutačno obuhvaćene oznakama KN 69071000, 69079020, 69079080, 69081000, 69089011, 69089020, 69089031, 69089051, 69089091, 69089093 i 69089099.
DUMPING
DAMPING
Market Economy Treatment
Pristup tržišnoga gospodarstva
Neither group requested market economy treatment under Article 2(7)(c) of the basic Regulation.
Ni jedna grupa nije zatražila primjenu pristupa tržišnoga gospodarstva u skladu s člankom 2. stavkom 7. točkom (c) Osnovne uredbe.
Analogue Country
Analogna zemlja
As set out above, the Commission proposed the United States of America as analogue country, as it had been in the previous investigation.
Kako je prethodno navedeno, Komisija je kao analognu zemlju predložila Sjedinjene Američke Države kao i u prethodnom ispitnom postupku.
The Commission also contacted companies in a number of other possible analogue countries, but received no replies or cooperation from any other company.
Komisija je stupila u kontakt i s društvima u nizu drugih mogućih analognih zemalja, ali ni jedno drugo društvo nije se odazvalo niti ponudilo suradnju.
The choice of the United States of America was therefore confirmed as appropriate.
Odabir Sjedinjenih Američkih Država stoga je potvrđen kao primjeren.